While Indian markets might temporarily be on a slippery slope amid significant foreign outflows, geopolitical tension and rising concerns if India is lagging behind in areas such as artificial intelligence and semiconductors, the country’s structural growth drivers remain intact, feels D-Street’s top bulls like Ramesh Damani and Sunil Singhania.

Speaking at a fireside session during the Groww India Investor Festival 2026 in Mumbai, both investors urged retail participants to ignore short-term market noise and stay focused on long-term wealth creation through disciplined investing.

“We have become used to markets delivering 15-20 percent returns every year after COVID. Markets do not move in a straight line,” Damani said, cautioning investors against drawing conclusions from short-term corrections or temporary underperformance.

Referring to past market cycles, Damani said benchmark indices across global markets have frequently moved sideways for long stretches, even while fundamentally strong companies continued to steadily create substantial shareholder value beneath the broader market’s muted performance.

“When I started my investing journey, the Sensex was below 1,000. Today it is above 80,000. There is no reason to believe India’s next 10-20 years will not continue to create massive wealth,” he said.

Addressing concerns over persistent foreign institutional investor outflows and India lagging peers such as Korea, Taiwan and the US in recent months, Damani argued that fears of a slowdown in domestic investor participation were overstated.
“Whenever foreigners sell, someone is buying those stocks. Domestic investors understand Indian businesses best, and they are backing Indian companies with conviction,” he said.FIIs have offloaded domestic equities worth Rs 2.06 lakh crore in 2026, remaining net sellers for the third successive month-to-date. They have sold shares worth Rs 14,231 crore, so far this month. In less than five months, foreign investment outflow has surpassed 2025 figures of Rs 1.66 lakh crore.

Also read: FIIs sell over Rs 2 lakh crore worth of Indian equities in 2026. What lies ahead?

Nifty is down over 7% on an year-to-date basis even as its Asian peers like Shanghai Composite (4%), Nikkei 225 (21%) and Kospi (74%) have outperformed the headline index. Its Wall Street rivals like Dow (2.5%) and Nasdaq Composite (13%) have also fared better.

Echoing a similar sentiment, Abakkus Asset Manager Founder Sunil Singhania said India’s economic model remains fundamentally stronger because of its consumption-led growth engine, though he acknowledged that India has not yet emerged as a dominant player in sectors such as semiconductors and deep technology.

“There is no doubt that several global companies have done phenomenally well in AI and semiconductors. But consumption and people ultimately sustain economies, and India remains one of the strongest long-term consumption stories globally,” Singhania said.

Both investors repeatedly stressed the importance of patience and compounding, warning retail investors against chasing speculative returns or shifting between trending asset classes.

“There is no secret to wealth creation. The real secret is compounding,” Damani said during the audience interaction, adding that investors should focus on quality businesses and allow investments time to grow.

Sectoral opportunities

Damani remains bullish on defence, infrastructure, logistics and energy-linked businesses, arguing they could emerge as long-term beneficiaries in an increasingly fragmented geopolitical environment.

“The world has changed. Every country now wants stronger self-defence and supply-chain independence,” he said, adding that investors would need to reposition portfolios for a changing global order.

Asset allocation: Gold/silver

The two investors also pushed back against the growing retail fascination with gold and silver following the sharp rally in precious metals.

Singhania called gold and silver as non-productive assets while emphasising the importance of equities, referring to them as growing assets. He recommended only limited allocation towards precious metals.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)

Birla Corporation reported a consolidated net profit at Rs 295 crore in the March-ended quarter versus Rs 257 crore in the year ago period, implying a 15% uptick. The profit after tax (PAT) is attributable to the owners of the parent.

The cement maker posted a marginal uptick in its revenue at Rs 2,836 crore in Q4FY26 was versus Rs 2,815 crore posted by the company in the corresponding quarter of the previous financial year. It was up 0.8%, year-on-year.

The company’s board recommended a dividend of Rs 12.50 per share on 7,70,05,347 ordinary shares for the financial Year 2025-26. It will be paid within 30 days from the date of approval by the shareholders at the company’s upcoming Annual General Meeting.

The PAT surged 459% quarter-on-quarter versus Rs 53 crore in Q3FY26 while the topline grew 31% compared to Rs 2,159 crore in the January-March quarter of FY26.

The company incurred expenses of Rs 2,522 crore in the quarter under review versus Rs 2,064 crore in Q3FY26 and Rs 2,497 crore in Q4FY25. This implies a 22% sequential growth in its expenses and a 1% YoY growth. The expenses were made on material used by the company, purchases of stock-in-trade, employee benefits and finance cost.

The profit before tax (PBT) stood at Rs 380 crore in Q4FY26 versus Rs 80 crore in Q3FY26 and Rs 328 crore in Q4FY25.
For the full financial year, PAT stood at Rs 558 crore versus Rs 295 crore in FY25, recording a jump of 89%. The topline was reported at Rs 9,656 crore in FY26 versus Rs 9,214 crore, a 5% rise.The debt-to-equity ratio in FY26 fell 5 bps to 0.51% versus 0.56% in the previous financial year.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)

This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SIVEF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

When parents receive a cerebral palsy diagnosis for their child, one of the first questions that surfaces is whether anything could have been done differently.

According to the CDC’s 2024 surveillance data, cerebral palsy affects approximately 3.3 per 1,000 children in the United States, making it the most common motor disability in childhood. As medical understanding of brain development and pregnancy complications has advanced, researchers have identified specific risk factors that contribute to cerebral palsy—some preventable, others beyond our current control.

The question of prevention matters more than ever as prenatal care standards evolve and birth practices continue to improve. For expectant parents and families already navigating this diagnosis, understanding the complex web of factors that can lead to cerebral palsy provides both clarity and a foundation for informed decision-making. This knowledge doesn’t change what’s already happened, but it can guide future pregnancies and help families understand the intricate biological processes that affect brain development during the most vulnerable periods of a child’s life.

Why Understanding Cerebral Palsy Causes Matters Today

Cerebral palsy represents a group of permanent movement and posture disorders caused by damage to the developing brain, typically occurring before, during, or shortly after birth. The complexity of this condition stems from the fact that multiple pathways can lead to the same outcome—brain injury that affects motor control and development.

Current research has moved far beyond the outdated assumption that most cerebral palsy cases result from birth trauma or oxygen deprivation during delivery. Scientists now understand that the majority of cases—roughly 70 to 80 percent—actually originate from events that occur during pregnancy, when the brain is forming its fundamental structures. This shift in understanding has profound implications for prevention strategies and helps explain why some children develop cerebral palsy despite what appears to be an uncomplicated birth.

The brain damage that causes cerebral palsy most commonly affects areas responsible for movement, balance, and posture. Depending on which brain regions are impacted and the extent of the damage, children may experience anything from mild coordination difficulties to severe physical disabilities affecting multiple limbs. What makes this condition particularly challenging to predict is that similar brain injuries can produce vastly different outcomes—one child might have subtle learning differences, while another requires extensive physical support.

Modern medical imaging and genetic testing have revealed that cerebral palsy often results from a combination of factors rather than a single catastrophic event. A child might have a genetic predisposition that makes their brain more vulnerable to injury, experience a maternal infection during a critical development window, and then encounter additional stress during birth. This layered risk model explains why prevention efforts must address multiple potential causes rather than focusing solely on delivery complications.

Understanding these complexities becomes crucial when families face decisions about future pregnancies or when pursuing complex birth injury cases that require detailed analysis of medical care standards. The timeline of brain development and the specific periods when different types of damage can occur directly influence both medical prevention strategies and legal considerations about when preventable harm may have occurred.

What Prenatal and Perinatal Factors Increase Cerebral Palsy Risk?

The period from conception through the first month after birth represents the highest-risk window for the brain injuries that cause cerebral palsy. During pregnancy, the developing brain undergoes rapid cell division and organization, making it particularly vulnerable to disruption from infections, inflammation, or reduced blood flow.

Maternal infections during pregnancy pose one of the most significant modifiable risk factors. When a pregnant woman contracts certain viral or bacterial infections—including cytomegalovirus, toxoplasmosis, rubella, or even severe urinary tract infections—the resulting inflammatory response can cross the placenta and interfere with fetal brain development. The timing of infection matters critically; infections during the second trimester often prove most damaging because that’s when crucial brain structures are forming.

Pregnancy complications that reduce oxygen or nutrient flow to the developing baby also increase cerebral palsy risk substantially. Placental problems like placenta previa or placental abruption can starve the brain of oxygen during critical development periods. Similarly, severe maternal conditions such as uncontrolled diabetes, high blood pressure, or thyroid disorders can compromise the intricate environment the developing brain requires.

Multiple pregnancies carry inherently higher risks, not just because of the increased likelihood of premature birth, but because of complications specific to sharing space in the womb. Twin-to-twin transfusion syndrome, where one baby receives too much blood flow and the other too little, can cause brain damage in either child. Even when one twin is lost during pregnancy, the surviving twin faces elevated cerebral palsy risk due to the sudden changes in blood flow and potential clotting complications.

The timing of birth itself plays a crucial role, with babies born before 32 weeks facing dramatically higher cerebral palsy rates—sometimes 40 to 100 times higher than full-term infants. Premature babies’ brains are not only less developed but also more susceptible to bleeding and infection. The delicate blood vessels in their developing brains can rupture under stress that a full-term baby’s brain would handle without injury.

How Genetic Factors Influence Cerebral Palsy

While environmental factors during pregnancy often take center stage in cerebral palsy discussions, genetic influences play a more significant role than many families realize. Recent research suggests that genetic factors may contribute to 10 to 15 percent of cerebral palsy cases, either as direct causes or by making children more vulnerable to other risk factors.

Single gene mutations can directly cause cerebral palsy-like symptoms, particularly in cases involving metabolic disorders or abnormal brain development. Mutations affecting genes responsible for brain cell migration, blood vessel formation, or cellular energy production can lead to the motor and cognitive challenges characteristic of cerebral palsy. These genetic forms often run in families and may be identifiable through genetic testing.

More commonly, genetic variations increase susceptibility to brain injury without directly causing cerebral palsy. Some children inherit genetic traits that make their brains more sensitive to inflammation, less able to recover from oxygen deprivation, or more prone to bleeding. When these children encounter additional risk factors—like maternal infection or premature birth—they’re more likely to sustain brain damage than genetically typical children facing the same challenges.

Chromosomal abnormalities represent another genetic pathway to cerebral palsy. Conditions like Down syndrome often include cerebral palsy as one component of a broader pattern of developmental differences. In these cases, the altered genetic blueprint affects multiple body systems, including the brain regions controlling movement and coordination.

The interaction between genetic predisposition and environmental factors explains why some families experience cerebral palsy in multiple children despite similar pregnancy care, while others face significant pregnancy complications without any lasting effects. Understanding these genetic components is increasingly important for family planning decisions and for developing personalized prevention strategies.

How Environmental Factors Affect Cerebral Palsy Development

Environmental influences during pregnancy extend far beyond obvious toxins to include factors that many families don’t recognize as risks. Maternal stress, whether from major life events, chronic illness, or socioeconomic pressures, can trigger inflammatory responses that affect fetal brain development. While normal daily stress poses little risk, severe or prolonged stress may increase cerebral palsy likelihood by disrupting the hormonal environment crucial for healthy brain formation.

Nutritional deficiencies during pregnancy, particularly deficits in folate, iron, or omega-3 fatty acids, can impair brain development and increase vulnerability to other risk factors. Maternal malnutrition doesn’t need to be severe to affect fetal brain development; even moderate deficiencies during critical development windows can have lasting consequences.

Exposure to certain medications during pregnancy requires careful risk-benefit analysis. While most prescription medications are safe, some antibiotics, anticonvulsants, and psychiatric medications may increase cerebral palsy risk if used during specific developmental periods. The challenge lies in balancing maternal health needs against potential fetal risks—sometimes treating maternal conditions actually reduces overall risk to the developing baby.

Environmental toxins including lead, mercury, and certain pesticides can cross the placental barrier and interfere with normal brain development. Even low-level exposures that wouldn’t affect adult health may disrupt the precise cellular processes required for proper brain formation. Geographic factors, occupational exposures, and household environments all contribute to cumulative toxin loads during pregnancy.

Which Birth Complications and Brain Development Issues Cause Cerebral Palsy?

The birth process itself, while representing only a small percentage of cerebral palsy causes, involves intense physical stresses that can occasionally overwhelm a baby’s developing brain. Prolonged labor or difficult deliveries sometimes reduce oxygen flow to the brain for periods long enough to cause permanent damage. However, contrary to historical assumptions, most babies tolerate even challenging deliveries without lasting neurological effects.

Hypoxic-ischemic encephalopathy—brain injury from oxygen deprivation—represents the most serious birth-related cause of cerebral palsy. This condition occurs when blood flow to the brain is severely compromised during delivery, often due to umbilical cord complications, placental problems, or maternal blood pressure crises. The extent of brain damage depends on both the severity and duration of oxygen deprivation, with some children recovering completely while others develop severe disabilities.

Neonatal strokes affect approximately 1 in 2,000 newborns and can occur before, during, or immediately after birth. These strokes—caused by blood clots or bleeding in the brain—often go unnoticed initially because newborns can’t communicate symptoms. Brain imaging may reveal stroke damage months later when parents notice delayed motor development or asymmetric movement patterns.

Infections during the newborn period pose particular dangers because babies’ immune systems are still developing. Bacterial meningitis, viral encephalitis, or severe sepsis can cause brain inflammation and damage that leads to cerebral palsy. Group B strep infections, transmitted from mother to baby during delivery, represent one of the most preventable causes of newborn brain infection.

Severe jaundice that goes untreated can cause a condition called kernicterus, where high levels of bilirubin damage brain cells controlling movement and hearing. While routine newborn screening has made kernicterus rare in developed countries, it remains a preventable cause of cerebral palsy when appropriate monitoring and treatment are delayed.

Brain hemorrhages in premature infants represent another critical pathway to cerebral palsy. The fragile blood vessels in developing brains can rupture from changes in blood pressure, oxygen levels, or blood flow that occur during intensive care treatment. While neonatal intensive care saves many lives, the interventions required for survival sometimes contribute to brain injury in the most vulnerable babies.

The period immediately following birth continues to pose risks as newborns adapt to breathing, maintaining body temperature, and managing blood sugar independently. Severe complications during this transition—particularly prolonged low blood sugar, persistent breathing difficulties, or temperature regulation problems—can stress the brain enough to cause lasting damage.

What Prevention Strategies Can Lower Cerebral Palsy Risk?

Modern prevention strategies focus on reducing known risk factors rather than eliminating cerebral palsy entirely, since many contributing factors remain beyond medical control. Comprehensive prenatal care represents the most effective prevention approach, starting with pre-conception counseling that addresses genetic risks, maternal health optimization, and lifestyle modifications that support healthy brain development.

Infection prevention during pregnancy offers some of the most tangible risk reduction opportunities. This includes routine screening for and treatment of urinary tract infections, group B strep testing near delivery, vaccination against preventable diseases, and careful food safety practices to avoid toxoplasmosis and listeria. While not all infections can be prevented, reducing exposure and ensuring prompt treatment when infections occur significantly lowers cerebral palsy risk.

Management of maternal health conditions before and during pregnancy can prevent many of the complications that threaten fetal brain development. Controlling diabetes, treating high blood pressure, managing thyroid disorders, and addressing blood clotting problems all contribute to creating the stable environment developing brains require. Sometimes this means adjusting medications or increasing monitoring frequency, but untreated maternal conditions typically pose greater risks than carefully managed treatment.

Timing of delivery decisions has evolved substantially as research reveals the optimal balance between fetal maturity and pregnancy risks. While preventing premature birth remains a priority, understanding when the risks of staying in the womb outweigh the risks of early delivery helps guide decisions about timing interventions. Advanced fetal monitoring and improved neonatal care have expanded the safety margin for these complex decisions.

Magnesium sulfate administration to mothers in preterm labor has emerged as one of the most evidence-based cerebral palsy prevention strategies. Research shows that magnesium sulfate given to women delivering before 32 weeks can reduce the risk of cerebral palsy in their babies by approximately 30 percent. This relatively simple intervention demonstrates how targeted prevention strategies can have meaningful impacts.

The reality is that many cerebral palsy cases occur despite excellent medical care and optimal conditions. Current prevention strategies can reduce risk but cannot eliminate it entirely. For families navigating this complex landscape, understanding both the possibilities and limitations of prevention provides a realistic framework for making informed decisions about pregnancy care and family planning. The goal is not perfection, but rather the best possible outcomes given current medical knowledge and individual circumstances.